Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hempure was a private U.S. consumer health and wellness company focused on hemp-derived cannabidiol products sold directly to consumers. Its product portfolio included CBD drops, capsules, gummies, balm, and pet products, marketed around wellness, relaxation, balance, and localized discomfort relief. Publicly available materials emphasize broad-spectrum or THC-free CBD formulations, lab testing, and GMP-compliant manufacturing standards rather than prescription drug development. The business appears to have operated primarily as a commercial nutraceutical and CBD brand rather than a biotech or pharmaceutical R&D company. As of the latest available information, the Hempure CBD website states that the company is closed for business.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hempure.